Comparative efficacyof fingolimod versus natalizumab in multiple sclerosis: a prospective multicenter observational study

Affiliation auteurs!!!! Error affiliation !!!!
TitreComparative efficacyof fingolimod versus natalizumab in multiple sclerosis: a prospective multicenter observational study
Type de publicationJournal Article
Year of Publication2015
AuteursLaplaud D.A, Barbin L., Rousseau C., Jousset N., Casey R., Debouverie M., Vukusic S., De Seze J., Brassat D., Wiertlewski S., Brochet B., Pelletier J., Vermersch P., Edan G., Lebrun-Frenay C., Clavelou P., Thouvenot E., Camdessanche J.-P, Tourbah A., Stankoff B., A. Khedr A, Cabre P., Papeix C., Berger E., Heinzlef O., Debroucker T., Moreau T., Gout O., Bourre B., Creange A., Labauge P., Magy L., Defer G., Foucher Y., OFSEP, SFSEP
JournalMULTIPLE SCLEROSIS JOURNAL
Volume21
Pagination62-63
Date PublishedSEP
Type of ArticleMeeting Abstract
ISSN1352-4585